Rituximab and ocrelizumab go head to head in randomized trial ...

A Norwegian-Swedish clinical trial published in the New England Journal of Medicine demonstrates that rituximab, a low-cost B ...

Increasing the Ocrevus dose used in treating MS provided no additional benefit versus the approved regimen in trials with over 1,500 patients.

Many recovering drug addicts (myself included) have a recurring nightmare: You wake up one morning and suddenly all of the work you have put into staying sober is gone. Maybe you’re returning to ...

Symptoms and frequency of relapses vary widely from person to person with the most common form of multiple sclerosis — and doctors aren’t entirely sure why. But, what exactly does a relapse look like?

MS is due to the body’s defence system, or immune system, attacking the insulating cover of myelin that protects the nerves. This damages the nerves and impairs their ability to pass on electric ...

Frexalimab (Sanofi), a novel, investigational second-generation inhibitor of the CD40 ligand, significantly reduced disease activity in relapsing multiple sclerosis (MS) and was well tolerated in a ...

Up to 85% of the people who receive a diagnosis of the neurodegenerative disorder multiple sclerosis (MS) have the relapsing-remitting (RR) disease course. This means that people have relapses -- also ...

Malaria and the Borrelia infection relapsing fever are diseases with similar symptoms that can occur simultaneously. In such cases, the malaria is moderated while the relapsing fever becomes more ...

Q: Who should I consult for relapsing fever? A: In case of fever that lasts for more than a week especially in endemic areas or in people traveling to areas where relapsing fever is prevalent, the ...

Multiple sclerosis is a disorder of the immune system, where the myelin coating the nerve cells is damaged by antibodies formed by the defence system of the body. This affects the functioning of the ...